β-Galactosidase-deficient mouse as an animal model for GM1-gangliosidosis

[1]  C. Scriver.  The Metabolic and Molecular Bases of Inherited Disease , 2001 .

[2]  Yoshiyuki Suzuki,et al.  Neurological manifestations of knockout mice with β-galactosidase deficiency , 1997, Brain and Development.

[3]  Michael P. McDonald,et al.  Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism , 1995, Nature Genetics.

[4]  L. Riboni,et al.  The Degradative Pathway of Gangliosides GM1 and GM2 in Neuro2a Cells by Sialidase , 1995, Journal of neurochemistry.

[5]  Y Ikawa,et al.  A novel ES cell line, TT2, with high germline-differentiating potency. , 1993, Analytical biochemistry.

[6]  T. Yagi,et al.  A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. , 1993, Analytical biochemistry.

[7]  E. Nanba,et al.  Organization of the mouse acid β-galactosidase gene , 1991 .

[8]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[9]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[10]  T. Orii,et al.  Screening test for urinary glycosaminoglycans and differentiation of various mucopolysaccharidoses. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[11]  Suzuki Yoshiyuki,et al.  Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of β-galactosidase molecules , 1982 .

[12]  A. Sewell.  An improved thin-layer chromatographic method for urinary oligosaccharide screening. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[13]  G. Glaser,et al.  CEREBRAL, CEREBELLAR, AND BRAIN STEM GANGLIOSIDES IN MICE SUSCEPTIBLE TO AUDIOGENIC SEIZURES , 1978, Journal of neurochemistry.

[14]  D. Harrington,et al.  Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency. , 1976, Science.

[15]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[16]  L. Wolfe,et al.  Characterization of oligosaccharides and glycopeptides excreted in the urine of GMl-gangliosidosis patients. , 1975, Biochemical and biophysical research communications.

[17]  B. Sheahan,et al.  GM1 gangliosidosis in friesian calves , 1973, The Journal of pathology.

[18]  H. J. Baker,et al.  Neuronal GM1 Gangliosidosis in a Siamese Cat with β-Galactosidase Deficiency , 1971, Science.

[19]  Kinuko Suzuki,et al.  CHEMICAL PATHOLOGY OF GM1‐GANGLIOSIDOSIS (GENERALIZED GANGLIOSIDOSIS) , 1969, Journal of neuropathology and experimental neurology.

[20]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[21]  L. Svennerholm.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. , 1957, Biochimica et biophysica acta.